Ecofibre share price on watch after doubling profits

The Ecofibre share price is on watch after the company reported a doubling of profits. It is successfully targeting a range of verticals

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ecofibre Ltd (ASX: EOF) share price is on watch this morning after an impressive earnings report. It produces non-psychoactive hemp products for distribution in the United States and Australia. The company's primary product is cannabidiol (CBD) which is used to create nutraceutical products. Other products in this category include dietary supplements, vitamins, fortified dairy products, and citrus fruits and many others. 

The company reported a 42% increase in top line revenues, and an eye watering 119% increase in net profit after tax (NPAT). The year of the coronavirus pandemic has been a foundational year for this innovating company. Indeed, it has built the infrastructure it needs to grow rapidly into a very large addressable market.

Why is the Ecofibre share price on watch?

The Ecofibre share price is likely to see an impact after announcing top line revenue reached $50.7 million in its first full year as a publicly listed company. In fact, the company's gross margin was 76%. This is the margin between revenue and the cost of producing the product. With the addition of all other operating costs, the NPAT margin was 25.9%. These large margins clearly show the high value nature of this business. Moreover, the company was able to achieve a return on equity (ROE) of 20.9%, while increasing net assets by 48.9%.

The company has a range of subsidiaries. However, most importantly for the Ecofibre share price is Ananda health. This is the leading nutraceutical product manufacturer in retail pharmaceutical sales channel in the United States. Moreover, Ananda health recently signed a deal with CVS Pharmacy, the largest retail pharmacy company in the US. This speaks highly of the quality of Ananda Health products.

Within Australia, all Ananda hemp products are available under the Special Access Scheme (SAS) and Authorised Prescriber scheme. Health practitioners are prescribing the product for a range of conditions. In fact, a close friend of mine with multiple sclerosis is using it.

Ecofibre food products are available at Woolworths Group Ltd (ASX: WOW) stores under the 'Macro' brand, and through selected IGA stores under the Ananda Food brand. In addition, these products are sold wholesale to food manufacturers and other distributors. This revenue stream is still unprofitable, but it has improved on FY19. 

New revenue streams

The company commercialised its new Hemp Black line of clothing in FY20. This project started off 2 years ago with technology development at Thomas Jefferson University. Even without the sustainability impacts, hemp fibre is lightweight and absorbent, and has three times the tensile strength of cotton. 

In April, the subsidiary was ready to launch with Yoga wear to demonstrate the quality and functionality of its technologies. However, fortunately it pivoted to masks and neck gaiters to help in the fight against coronavirus. As a result, the subsidiary broke even in FY20. On 29 July, the company announced the acquisition of a portfolio of companies under the business TexInnovate, an advanced textile manufacturer. This gives Hemp Black capabilities throughout the value chain. TexInnovate also brings a number of clients with it. 

Alongside the financial information above, I think this is another demonstration of the managerial capability of Ecofibre. As well as its ability to pivot rapidly. Patents are pending on clothing and mask designs, as well as many patents over the fabric and processes the company has developed. 

Foolish Takeaway

I think the Ecofibre share price is a growth opportunity for ASX investors. It is the sector leader in the very important retail pharmacy channel for its nutraceutical product. This sector that is likely to be worth greater than $722 billion globally by 2027. This gives it a first mover advantage in a wide open market; just as Afterpay Ltd (ASX: APT) had in Australia in the beginning. Furthermore, the company is committed to continue with clinical testing and research. 

For me personally, the actions of management so far give me a strong sense of their competence and business acumen. I believe they are very well positioned for growth in a range of areas, although I am not sure about the food revenue stream. Regardless of that, the company is valued at $919.97 million and has a price to earnings ratio of 63.36. I think the high earnings multiple is justified, and I see this as a strong growth candidate over the next 12 months and beyond.

Motley Fool contributor Daryl Mather has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO and Woolworths Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 small-cap ASX healthcare shares 'with strong prospects'

Fund manager IML discusses why these 3 ASX healthcare shares are likely to rise in value.

Read more »

Magnifying glass on a rising interest rate graph.
Share Market News

Will the RBA finally cut interest rates next week?

Let's see what economists are saying about the central bank's meeting.

Read more »

A couple sits on a sofa, each clutching their heads in horror and disbelief, while looking at a laptop screen.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors endured a rough Friday to close the trading week today.

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Broker Notes

7 ASX All Ords shares elevated to 'strong buy' status in October

The brokers turned bullish on these ASX companies last month.

Read more »

A businessman compares the growth trajectory of property versus shares.
Share Market News

How ASX shares vs. property performed in October

The national home value rose for the 21st consecutive month while the ASX 200 dipped.

Read more »

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

The worst 3 ASX 200 stocks to buy and hold in October unmasked

You would have done well to avoid these three ASX 200 stocks in October.

Read more »

A female Woolworths customer leans on her shopping trolley as she rests her chin in her hand thinking about what to buy for dinner while also wondering why the Woolworths share price isn't doing as well as Coles recently
52-Week Lows

Why is the Woolworths share price at its lowest point since 2020?

We haven't seen Woolies shares this low since COVID.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why AFT, Amcor, Corporate Travel, and Macquarie shares are falling today

These shares are ending the week in the red. But why?

Read more »